comparemela.com

Latest Breaking News On - Very severe chronic obstructive pulmonary disease - Page 1 : comparemela.com

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International.

United-states
San-diego
California
Puerto-rico
American
America
Kate-meyer
Jessica-akopyan
Justin-claeys
Lymphopoietin-isoforms
Jay-bradner
World-most-innovative-companies

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD .

China
Japan
San-diego
California
United-states
Brazil
Brightling
East-sussex
United-kingdom
Cambridge
Cambridgeshire
America

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.